As per MRFR analysis, the India Cancer Supportive Care Market Size was estimated at 1.02 (USD Billion) in 2023. The India Cancer Supportive Care Market Industry is expected to grow from 1.05(USD Billion) in 2024 to 1.53 (USD Billion) by 2035. The India Cancer Supportive Care Market CAGR (growth rate) is expected to be around 3.522% during the forecast period (2025 - 2035).
The India Cancer Supportive Care Market is currently undergoing substantial growth as a result of the growing emphasis on the enhancement of patients' quality of life and the increasing incidence of cancer. The growing recognition of the significance of supportive therapies in conjunction with conventional cancer treatments is one of the primary market drivers. This has resulted in a heightened acceptance of palliative care services and interventions that are designed to improve nutrition, alleviate symptoms, and improve emotional well-being. Additionally, the national cancer control program, a government initiative in India, is designed to guarantee patients access to comprehensive cancer care and support services, thereby stimulating market expansion.
By incorporating traditional Indian therapeutic practices, such as Ayurveda, into supportive care frameworks and expanding community-based care programs, opportunities in the India Cancer Supportive Care Market can be captured. This may be particularly appealing to patients and their families, who are interested in comprehensive cancer care. Additionally, the establishment of patient support groups, educational resources, and financial assistance programs can be facilitated through collaboration among healthcare providers, NGOs, and government bodies.. Telemedicine and digital health platforms have experienced a recent surge in popularity, which has improved access to supportive care services in rural regions of India where healthcare facilities may be scarce.
The increasing utilization of mobile applications for remote consultations and symptom monitoring is facilitating the more effective management of patients' conditions. Furthermore, there is an increasing emphasis on psychosocial support and personalized care plans, which allows patients to receive treatment experiences that are both holistic and customized. In general, the changing landscape is indicative of a dedication to the multifaceted requirements of cancer patients in India, which is fostering innovation and progress in the supportive care sector.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
Increasing Cancer Incidence in India
The increasing incidence of cancer in India is one of the primary drivers of the India Cancer Supportive Care Market Industry. The National Cancer Registry Programme (NCRP) reported that cancer cases in India are projected to rise significantly due to lifestyle changes, urbanization, and population growth. The Indian government estimates that by 2025, there will be around 1.4 million new cancer cases annually, up from roughly 1.1 million in 2020. This trend necessitates enhanced supportive care services to manage symptoms and improve the quality of life for patients, directly fueling market growth.With organizations like the Indian Council of Medical Research constantly updating cancer statistics and guidelines, health policies are increasingly focusing on full-spectrum cancer care, which includes supportive measures. This heightened awareness from the regulatory segment amplifies the need for supportive care, thereby benefiting market dynamics.
Government Initiatives and Funding
Government initiatives toward cancer care have a significant impact on the India Cancer Supportive Care Market Industry. The National Health Mission and various state-sponsored health schemes have started to integrate palliative and supportive care into comprehensive cancer services. This is reflected in the allocation of funds exceeding millions of Indian Rupees for building specialized cancer hospitals and research centers focused on supportive care.The Indian government aims to ensure access to affordable and quality healthcare services, including supportive care for cancer patients, leading to an increase in service providers and competition. As these initiatives gain more traction, the supportive care market is expected to witness substantial growth fueled by these policies.
Rising Awareness Among Patients and Caregivers
There is a growing awareness of supportive care among patients and caregivers in India, which is significantly influencing the India Cancer Supportive Care Market Industry. Surveys conducted by reputable health organizations indicate that nearly 65% of patients seek information on palliative care options to alleviate pain and enhance their well-being. The increasing number of cancer awareness campaigns led by non-governmental organizations and healthcare providers highlights the importance of emotional, financial, and physical support for cancer patients.This boost in awareness not only drives demand for supportive care services but also encourages healthcare providers to expand their offerings, thus further developing the market landscape.
The Type segment of the India Cancer Supportive Care Market encompasses various categories such as Erythropoiesis-Stimulating Agents (ESA), Granulocyte-Colony Stimulating Factors (G-CSFs), antiemetics, bisphosphonates, opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and other essential agents. Focusing on this segmentation reveals that each category plays a crucial role in managing the symptoms and side effects experienced by cancer patients undergoing treatment. For instance, ESAs are vital for addressing anemia, a common complication resulting from cancer therapies; their significance is underscored by the growing incidence of anemia in oncology patients.Similarly, G-CSFs are instrumental in reducing the risk of febrile neutropenia, a serious side effect that can complicate chemotherapy, thus facilitating uninterrupted treatment regimens. The antiemetics segment addresses nausea and vomiting, distressing side effects that can significantly affect quality of life; their role is critical as more patients complete their chemo cycles without interruption.
Bisphosphonates stand out in managing bone complications associated with metastatic cancers, assisting in the prevention of skeletal-related events, which are common in late-stage prostate and breast cancers.Opioids are recognized for their efficacy in managing severe pain, often debilitating for those battling cancer, making their availability and accessibility critical. NSAIDs contribute to pain management and symptomatic relief, proving to be essential in the palliative care of cancer patients. Additional categories in this sector, categorized as 'Others', possibly include innovative supportive therapies and novel agents that enhance the quality of cancer care.
Several factors, such as advancements in treatment options, an increase in the prevalence of cancer, and the growing awareness about supportive therapies among healthcare providers in India influence the market for these types.This diversification within the Type segment reflects an adaptation to the evolving needs of cancer patients, informing product development and healthcare policies, which are crucial for enhancing patient outcomes in India. Overall, the Type segment in the India Cancer Supportive Care Market captures a comprehensive overview of the various therapeutic approaches utilized to alleviate the burden of cancer treatment.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The India Cancer Supportive Care Market, particularly within the Application segment, is witnessing a notable evolution driven by the increasing prevalence of various cancer types and a growing awareness of supportive care. Among different applications, Breast Cancer care is particularly significant due to the high incidence rates reported in Indian women, necessitating robust supportive care solutions to improve quality of life during treatment. Lung Cancer also emerges prominently, given rising pollution levels and lifestyle changes. Colorectal Cancer is on the rise as screening methods advance, while Prostate Cancer is gaining attention, particularly in aging male populations, further emphasizing the need for tailored supportive interventions.
Liver Cancer and Stomach Cancer, though less frequently discussed, remain critical due to their challenging treatment regimens and the spectrum of associated nutritional and psychological support required. The other category encapsulates a range of oncological issues, highlighting the multifaceted challenges patients face. Overall, the India Cancer Supportive Care Market segmentation illustrates vital growth potential through raising awareness, enhancing care models, and addressing diverse patient needs across the country. The incorporation of technological advances in care management and an increase in government initiatives to support cancer treatment further bolster this segment's growth trajectory.
The Distribution Channel segment within the India Cancer Supportive Care Market plays a critical role in ensuring that patients have access to necessary medical support. Different avenues, such as Hospital Pharmacies, Drug Stores, Retail Pharmacies, and Online Providers, serve distinct functions in the overall distribution network. Hospital Pharmacies are pivotal in providing specialized cancer care medications directly to patients undergoing treatment, ensuring personalized support and rapid access. Drug Stores and Retail Pharmacies contribute by offering convenience and over-the-counter supportive care products, catering to a broader demographic of patients and caregivers.
Online Providers are becoming increasingly significant in this landscape, providing a convenient platform for purchasing medications and supportive care products, especially amidst the rising trend of e-commerce in India. The digitalization of healthcare services in India is further driving this channel's growth, addressing the need for timely access to products. Overall, the segmentation of these distribution channels enhances market reach and improves patient access, directly influencing the effectiveness of cancer supportive care in India.
The India Cancer Supportive Care Market is characterized by a growing emphasis on enhancing the quality of life for patients undergoing cancer treatment. This sector encompasses a range of services, including pain management, nutritional support, psychological counseling, and palliative care, which are critical for addressing the multifaceted needs of cancer patients. The competitive landscape is shaped by several key players and institutions that are focused on providing comprehensive care solutions. The market is evolving rapidly due to increasing cancer incidence in India, advancements in treatment methodologies, and a heightened recognition of the importance of supportive care in holistic cancer management.
This environment has fostered collaboration and innovations among healthcare providers, ultimately improving patient outcomes and satisfaction.Rajasthan Cancer Institute is a prominent player in the Indian Cancer Supportive Care Market, known for its robust approach towards patient care and support. This institute offers specialized services that include pain management, emotional counseling, and dietary planning aimed at improving the overall well-being of cancer patients. With a dedicated team of oncologists, nurses, and supportive care specialists, Rajasthan Cancer Institute has established itself as a trusted institution in this field. Its strength lies in its focus on integrating supportive care with oncology services, enabling a comprehensive treatment approach that caters to both the physical and psychological needs of patients.
Additionally, the institute's outreach programs and community support initiatives further reinforce its presence in the market, demonstrating a commitment to elevating the standards of cancer care in the region.Manipal Hospitals, a leading healthcare provider in India, has made significant contributions to the Cancer Supportive Care Market by offering a wide range of services tailored to the needs of cancer patients. The hospital network emphasizes an integrated approach that combines expertise in oncology with essential supportive care services. Key offerings include patient education, nutritional counseling, psychosocial support, and symptom management, which underscore the hospital's commitment to improving patient quality of life.
With an extensive network of hospitals across India, Manipal Hospitals has built a strong presence in both urban and suburban areas, making its services accessible to a diverse patient population. The organization has also engaged in strategic partnerships, mergers, and acquisitions that have bolstered its capabilities in cancer care, enabling it to stay at the forefront of advancements in treatment and supportive services. This multifaceted strategy underscores the hospital's strengths in providing comprehensive, patient-centered care for those affected by cancer.
Key Companies in the India Cancer Supportive Care Market Include
The India Cancer Supportive Care Market has recently witnessed significant developments, particularly with hospitals enhancing their supportive care services. The Rajasthan Cancer Institute has successfully expanded its services to encompass advanced palliative care programs, effectively addressing patient needs during and post-treatment. Manipal Hospitals and Apollo Hospitals Enterprise are actively adopting new technologies and treatment approaches to provide better supportive care, emphasizing personalized treatments. A notable acquisition was made in August 2023 when HCG Oncology acquired a specialized pain management clinic, further broadening its reach in supportive care.
The Tata Memorial Centre continues to pave the way in Research and Development, focusing on innovative interventions to improve the quality of life for cancer patients. In addition, Dr. Lal PathLabs has initiated collaborations aimed at comprehensive patient support and enhanced diagnostic services. The growth prospects within the India Cancer Supportive Care Market are fueled by increasing cancer prevalence, which is projected to reach 1.57 million new cases in 2023, according to government health reports. Companies like Fortis Healthcare and Narayana Health are expanding their cancer services, reflecting a concerted effort towards comprehensive care and treatment modalities over the past couple of years.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 1.02(USD Billion) |
| MARKET SIZE 2024 | 1.05(USD Billion) |
| MARKET SIZE 2035 | 1.53(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.522% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Rajasthan Cancer Institute, Manipal Hospitals, Apollo Hospitals Enterprise, HCG Oncology, Synergy Oncology, Tata Memorial Centre, B.P. Poddar Hospital, Max Healthcare, Dr. Lal PathLabs, Fortis Healthcare, Narayana Health, KIMS Hospitals, Birla Cancer Centre, OncoLife Cancer Centre, Medanta |
| SEGMENTS COVERED | Type, Application, Distribution Channel |
| KEY MARKET OPPORTUNITIES | Telehealth for cancer patients, Nutritional supplements growth, Palliative care services expansion, Mental health support programs, Integrative treatments adoption |
| KEY MARKET DYNAMICS | rising cancer incidence, increasing awareness programs, growing geriatric population, advancements in treatment options, expansion of healthcare infrastructure |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Cancer Supportive Care Market is anticipated to be valued at 1.05 billion USD in 2024.
By 2035, the India Cancer Supportive Care Market is projected to reach a value of 1.53 billion USD.
The market is expected to grow at a CAGR of 3.522% from 2025 to 2035.
In 2024, Erythropoiesis-Stimulating Agents (ESA) are projected to have the highest market value at 0.3 billion USD.
The market value of G-CSFs is expected to be 0.25 billion USD in 2024.
Key players include Rajasthan Cancer Institute, Apollo Hospitals, HCG Oncology, and Tata Memorial Centre among others.
The market for bisphosphonates is expected to grow from 0.15 billion USD in 2024 to 0.25 billion USD by 2035.
Urbanization and increasing healthcare access in regions across India will positively impact market growth.
Challenges include high treatment costs and limited patient awareness regarding supportive care options.
Government initiatives aimed at improving cancer care and research funding will drive market growth significantly.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
